Phase 1 study comapre Docecal and Taxotere in metastatic breast cancer

Trial Profile

Phase 1 study comapre Docecal and Taxotere in metastatic breast cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Feb 2018

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Breast cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Feb 2018 According to an Oasmia Pharmaceutical media release, 228 patients had been enrolled in two studied of Docecal in comparison with Taxotere (CTP 293315 and CTP 293313 ) from 17 clinical sites in five countries.
    • 22 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top